BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16606943)

  • 1. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
    Khan OA
    Neurology; 2006 Apr; 66(7):1131-2; author reply 1131-2. PubMed ID: 16606943
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
    Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
    Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
    Garbern JY
    J Neurol Sci; 2005 Feb; 228(2):201-3. PubMed ID: 15694206
    [No Abstract]   [Full Text] [Related]  

  • 4. Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype.
    Plecko B; Stöckler-Ipsiroglu S; Gruber S; Mlynarik V; Moser E; Simbrunner J; Ebner F; Bernert G; Harrer G; Gal A; Prayer D
    Neuropediatrics; 2003 Jun; 34(3):127-36. PubMed ID: 12910435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PLP mutants from mouse to man.
    Duncan ID
    J Neurol Sci; 2005 Feb; 228(2):204-5. PubMed ID: 15694207
    [No Abstract]   [Full Text] [Related]  

  • 6. Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.
    Vaurs-Barrière C; Deville M; Sarret C; Giraud G; Des Portes V; Prats-Viñas JM; De Michele G; Dan B; Brady AF; Boespflug-Tanguy O; Touraine R
    Ann Neurol; 2009 Jan; 65(1):114-8. PubMed ID: 19194886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin mishaps.
    Barkovich AJ
    Ann Neurol; 2007 Aug; 62(2):107-9. PubMed ID: 17683086
    [No Abstract]   [Full Text] [Related]  

  • 8. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
    McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
    Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelination of a fetus with Pelizaeus-Merzbacher disease: immunopathological study.
    Shiraishi K; Itoh M; Sano K; Takashima S; Kubota T
    Ann Neurol; 2003 Aug; 54(2):259-62. PubMed ID: 12891682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease.
    Fattal-Valevski A; DiMaio MS; Hisama FM; Hobson GM; Davis-Williams A; Garbern JY; Mahoney MJ; Kolodny EH; Pastores GM
    J Child Neurol; 2009 May; 24(5):618-24. PubMed ID: 19151366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the natural history of Pelizaeus-Merzbacher disease.
    Mayer JA; Griffiths IR; Goldman JE; Smith CM; Cooksey E; Radcliff AB; Duncan ID
    Neurobiol Dis; 2015 Mar; 75():115-30. PubMed ID: 25562656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelizaeus Merzbacher disease: dysmyelination versus demyelination.
    Akinaga K; Lee TY; Montenegro MA
    Arq Neuropsiquiatr; 2016 Jan; 74(1):81. PubMed ID: 26486495
    [No Abstract]   [Full Text] [Related]  

  • 13. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted SOX10 regulation of GJC2 transcription causes Pelizaeus-Merzbacher-like disease.
    Osaka H; Hamanoue H; Yamamoto R; Nezu A; Sasaki M; Saitsu H; Kurosawa K; Shimbo H; Matsumoto N; Inoue K
    Ann Neurol; 2010 Aug; 68(2):250-4. PubMed ID: 20695017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus-Merzbacher disease.
    Shimojima K; Okumura A; Ikeno M; Nishimura A; Saito A; Saitsu H; Matsumoto N; Yamamoto T
    Brain Dev; 2015 Mar; 37(3):281-5. PubMed ID: 24974158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
    Takanashi J
    Magn Reson Med Sci; 2015; 14(2):85-91. PubMed ID: 26185828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic hypertrophy in dysmyelination influences the diffusion anisotropy of white matter.
    Harsan LA; Poulet P; Guignard B; Parizel N; Skoff RP; Ghandour MS
    J Neurosci Res; 2007 Apr; 85(5):935-44. PubMed ID: 17278151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton MR spectroscopy in connatal Pelizaeus-Merzbacher disease.
    Spalice A; Popolizio T; Parisi P; Scarabino T; Iannetti P
    Pediatr Radiol; 2000 Mar; 30(3):171-5. PubMed ID: 10755756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelizaeus-Merzbacher Disease: A Caregiver Assessment of Disease Impact.
    Moore KM; Wolf NI; Hobson G; Bowyer K; McSherry J; Hartin G; Wilde C; Shapiro S; Frank J; Manley D; Junge C
    J Child Neurol; 2023 Feb; 38(1-2):78-84. PubMed ID: 36744386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duplication of the PLP gene and the classical form of Pelizaeus-Merzbacher disease].
    Blanco-Barca MO; Eirís-Puñal J; Soler-Regal C; Castro-Gago M
    Rev Neurol; 2003 Sep 1-15; 37(5):436-8. PubMed ID: 14533091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.